BlackRock Investment Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $1.63M | Sell |
134,303
-523
| -0.4% | -$6.36K | ﹤0.01% | 2362 |
|
2016
Q3 | $1.24M | Buy |
134,826
+5,440
| +4% | +$50K | ﹤0.01% | 2513 |
|
2016
Q2 | $1.23M | Buy |
129,386
+1,398
| +1% | +$13.3K | ﹤0.01% | 2474 |
|
2016
Q1 | $902K | Buy |
127,988
+933
| +0.7% | +$6.58K | ﹤0.01% | 2550 |
|
2015
Q4 | $1.33M | Buy |
127,055
+1,160
| +0.9% | +$12.1K | ﹤0.01% | 2380 |
|
2015
Q3 | $842K | Sell |
125,895
-3,641
| -3% | -$24.4K | ﹤0.01% | 2716 |
|
2015
Q2 | $870K | Buy |
129,536
+15,062
| +13% | +$101K | ﹤0.01% | 2870 |
|
2015
Q1 | $776K | Sell |
114,474
-743
| -0.6% | -$5.04K | ﹤0.01% | 2685 |
|
2014
Q4 | $923K | Sell |
115,217
-1,852
| -2% | -$14.8K | ﹤0.01% | 2596 |
|
2014
Q3 | $412K | Buy |
117,069
+3,640
| +3% | +$12.8K | ﹤0.01% | 3060 |
|
2014
Q2 | $542K | Buy |
113,429
+20,021
| +21% | +$95.7K | ﹤0.01% | 2987 |
|
2014
Q1 | $887K | Buy |
93,408
+16,642
| +22% | +$158K | ﹤0.01% | 2576 |
|
2013
Q4 | $499K | Sell |
76,766
-1,204
| -2% | -$7.83K | ﹤0.01% | 2935 |
|
2013
Q3 | $590K | Buy |
+77,970
| New | +$590K | ﹤0.01% | 2808 |
|